vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and SunOpta Inc. (STKL). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $205.4M, roughly 1.3× SunOpta Inc.). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs 0.4%, a 0.3% gap on every dollar of revenue. On growth, SunOpta Inc. posted the faster year-over-year revenue change (16.6% vs -16.5%). SunOpta Inc. produced more free cash flow last quarter ($12.1M vs $3.4M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
SunOpta, Inc. is a multi-national food and mineral company headquartered in Eden Prairie, Minnesota and founded in 1973 in Canada.
HCM vs STKL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $205.4M |
| Net Profit | $2.0M | $816.0K |
| Gross Margin | 37.7% | 12.4% |
| Operating Margin | -13.2% | 3.3% |
| Net Margin | 0.7% | 0.4% |
| Revenue YoY | -16.5% | 16.6% |
| Net Profit YoY | -83.6% | 113.1% |
| EPS (diluted) | $0.00 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | — | ||
| Q3 25 | — | $205.4M | ||
| Q2 25 | $277.7M | $191.5M | ||
| Q1 25 | $324.5M | $201.6M | ||
| Q4 24 | — | $193.9M | ||
| Q3 24 | — | $175.9M | ||
| Q2 24 | $305.7M | $169.5M | ||
| Q1 24 | — | $184.4M |
| Q4 25 | $2.0M | — | ||
| Q3 25 | — | $816.0K | ||
| Q2 25 | $455.0M | $4.4M | ||
| Q1 25 | $11.9M | $4.8M | ||
| Q4 24 | — | $-8.7M | ||
| Q3 24 | — | $-6.2M | ||
| Q2 24 | $25.8M | $-5.3M | ||
| Q1 24 | — | $2.9M |
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | 12.4% | ||
| Q2 25 | 0.1% | 14.8% | ||
| Q1 25 | 48.0% | 15.0% | ||
| Q4 24 | — | 10.9% | ||
| Q3 24 | — | 13.0% | ||
| Q2 24 | 41.1% | 12.5% | ||
| Q1 24 | — | 16.8% |
| Q4 25 | -13.2% | — | ||
| Q3 25 | — | 3.3% | ||
| Q2 25 | -1.3% | 5.5% | ||
| Q1 25 | -5.0% | 5.2% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | -9.0% | 1.2% | ||
| Q1 24 | — | 5.5% |
| Q4 25 | 0.7% | — | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | 163.8% | 2.3% | ||
| Q1 25 | 3.7% | 2.4% | ||
| Q4 24 | — | -4.5% | ||
| Q3 24 | — | -3.5% | ||
| Q2 24 | 8.4% | -3.1% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | $0.00 | — | ||
| Q3 25 | — | $0.01 | ||
| Q2 25 | $0.52 | $0.03 | ||
| Q1 25 | $0.01 | $0.04 | ||
| Q4 24 | — | $-0.08 | ||
| Q3 24 | — | $-0.05 | ||
| Q2 24 | $0.03 | $-0.04 | ||
| Q1 24 | — | $0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $2.2M |
| Total DebtLower is stronger | $93.2M | $250.8M |
| Stockholders' EquityBook value | $1.2B | $162.8M |
| Total Assets | $1.8B | $694.1M |
| Debt / EquityLower = less leverage | 0.08× | 1.54× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | — | ||
| Q3 25 | — | $2.2M | ||
| Q2 25 | $1.4B | $2.2M | ||
| Q1 25 | $836.1M | $2.3M | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | — | $2.9M | ||
| Q2 24 | $802.5M | $3.2M | ||
| Q1 24 | — | $1.5M |
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | $250.8M | ||
| Q2 25 | $93.4M | $263.3M | ||
| Q1 25 | $82.8M | $260.6M | ||
| Q4 24 | — | $265.2M | ||
| Q3 24 | — | $289.9M | ||
| Q2 24 | $82.1M | $303.1M | ||
| Q1 24 | — | $258.8M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | — | $162.8M | ||
| Q2 25 | $1.2B | $159.8M | ||
| Q1 25 | $759.9M | $154.8M | ||
| Q4 24 | — | $148.6M | ||
| Q3 24 | — | $155.0M | ||
| Q2 24 | $740.1M | $158.8M | ||
| Q1 24 | — | $163.6M |
| Q4 25 | $1.8B | — | ||
| Q3 25 | — | $694.1M | ||
| Q2 25 | $1.8B | $704.9M | ||
| Q1 25 | $1.3B | $690.7M | ||
| Q4 24 | — | $668.5M | ||
| Q3 24 | — | $699.3M | ||
| Q2 24 | $1.3B | $704.7M | ||
| Q1 24 | — | $671.8M |
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | 1.54× | ||
| Q2 25 | 0.08× | 1.65× | ||
| Q1 25 | 0.11× | 1.68× | ||
| Q4 24 | — | 1.78× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | 0.11× | 1.91× | ||
| Q1 24 | — | 1.58× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $16.3M |
| Free Cash FlowOCF − Capex | $3.4M | $12.1M |
| FCF MarginFCF / Revenue | 1.2% | 5.9% |
| Capex IntensityCapex / Revenue | 1.8% | 2.1% |
| Cash ConversionOCF / Net Profit | 4.21× | 20.03× |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $36.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | — | ||
| Q3 25 | — | $16.3M | ||
| Q2 25 | $-72.9M | $-4.5M | ||
| Q1 25 | $40.3M | $22.3M | ||
| Q4 24 | — | $33.1M | ||
| Q3 24 | — | $17.2M | ||
| Q2 24 | $-39.8M | $-5.6M | ||
| Q1 24 | — | $5.3M |
| Q4 25 | $3.4M | — | ||
| Q3 25 | — | $12.1M | ||
| Q2 25 | $-82.2M | $-9.2M | ||
| Q1 25 | $32.5M | $9.5M | ||
| Q4 24 | — | $24.0M | ||
| Q3 24 | — | $11.7M | ||
| Q2 24 | $-49.9M | $-15.3M | ||
| Q1 24 | — | $-2.3M |
| Q4 25 | 1.2% | — | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | -29.6% | -4.8% | ||
| Q1 25 | 10.0% | 4.7% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | -16.3% | -9.0% | ||
| Q1 24 | — | -1.2% |
| Q4 25 | 1.8% | — | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | 3.3% | 2.5% | ||
| Q1 25 | 2.4% | 6.3% | ||
| Q4 24 | — | 4.7% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | 3.3% | 5.7% | ||
| Q1 24 | — | 4.1% |
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | 20.03× | ||
| Q2 25 | -0.16× | -1.03× | ||
| Q1 25 | 3.38× | 4.63× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.54× | — | ||
| Q1 24 | — | 1.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
STKL
| Beverages And Broths | $161.4M | 79% |
| Fruit Snacks | $40.9M | 20% |
| Ingredients | $3.1M | 2% |
